SCHEMBL7365546

SCHEMBL7365546

COc1cc(C(=O)c2ccccc2C(F)(F)F)ccc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.60
SLC22A8 Q8TCC7 1/20 0.60
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
RAB9A P51151 2/20 0.53
HTT P42858 1/20 0.51
MAPT P10636 4/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
HPGD P15428 1/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 1/20 0.49
ALDH1A1 P00352 3/20 0.46
GAA P10253 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HSD17B2 P37059 1/20 0.46
TNF P01375 1/20 0.46
IL6 P05231 1/20 0.46
APP P05067 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15988945 0.85 CTNNB1 (0.56) SLC22A6SLC22A8MEN1KMT2ARAB9A
SCHEMBL10623624 0.83 KMT2A (0.51) MEN1KMT2ARAB9AHTTMAPT
SCHEMBL7367690 0.82 SLC22A6 (0.66) SLC22A6SLC22A8MEN1KMT2ARAB9A
SCHEMBL10428298 0.81 SMN1; SMN2 (0.51) HTTMAPTLMNAHSD17B10ALDH1A1
SCHEMBL27182902 0.80 SLC22A6 (0.68) SLC22A6SLC22A8MEN1KMT2ARAB9A
SCHEMBL7364817 0.80 SLC22A6 (0.68) SLC22A6SLC22A8MEN1KMT2ARAB9A
SCHEMBL3586390 0.80 SLC22A6 (0.55) SLC22A6SLC22A8MEN1KMT2ARAB9A
SCHEMBL7375095 0.79 NPC1 (0.60) MEN1KMT2ARAB9AKDM4EHPGD
SCHEMBL10619331 0.79 SMN1; SMN2 (0.46) KDM4ELMNAALDH1A1GAASMN1; SMN2
SCHEMBL7368597 0.79 SLC22A6 (0.66) SLC22A6SLC22A8MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed